Applied DNA Sciences Inc - APDN Net Assets per Single Share

Graphic logo of Applied DNA Sciences (APDN)

Applied DNA Sciences ensures supply chain transparency through the digital verification of DNA markers. Business protection is based on exclusive LinearRx patents under strict biocontrol conditions. Diversified transport routes guarantee the uninterrupted shipment of synthetic components. The adjusted book value per share clearly demonstrates the dynamics of net assets, where the 8.14 indicator expresses the current state of the metric.

Applied DNA (APDN) Equity per Share: for the period 07/04/2022 - 10/07/2025

Summary analytical data breakdowns for adnas.com (APDN)

- price and consensus price forecast:
Stock Price Applied DNA|APDN - Broker Consensus Forecast
- market capitalization data:
Market Value Applied DNA Sciences, Inc.|APDN - Business Value
- book capitalization data:
Book Value per Share Applied DNA Sciences|APDN - Accounting Capitalization|Market Value to Book Value Ratio adnas.com|APDN - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Applied DNA Sciences|APDN - Long-Term Debt to Capital|Short-Term Debt to Capital Applied DNA Sciences, Inc.|APDN - Company Aggregate Debts|Debt to Book Capitalization Ratio Applied DNA Sciences, Inc.
Fundamental company valuation:APDN, Applied DNA
Manufactured products of adnas.com

DNA component deliveries and the operations of LineaRx form the current material basis of Applied DNA Sciences (APDN), determining the actual net asset value. This metric measures the equity per share, reflecting the fundamental protection of investments through the value of equipment and inventories, which allows for an assessment of the business's intrinsic stability via the consolidated book value per share.

Competitor analysis for Applied DNA Sciences

Tempus AI, Inc. (TEM) - Book Value per Share|QGEN: Equity per Share|Net Assets per Single Share Ionis Pharmaceuticals|repligen.com (RGEN) - Equity per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|Twist Bioscience, Inc. - Book Value per Share|TXG: Book Value per Share|Net Assets per Single Share Intellia (NTLA)|STOK (Stoke Corp) - Share Book Value|Net Assets per Single Share BioLife Solutions, Inc. BLFS|Share Book Value WVE|Net Assets per Single Share Maze Therapeutics (MAZE)|Net Assets per Single Share Sionna Therapeutics, Inc. (SION)|Book Value per Share PRME|Net Assets per Share Taysha Corp TSHA|QURE (uniQure N.V.) - Book Value per Share|MGTX - Net Asset Value per Share|Book Value per Share REGENXBIO|Equity per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp|Book Value per Share Benitec Biopharma Inc. BNTC|Equity per Share DSGN (designtx.com)|RCKT - Net Assets per Single Share|Equity per Share 4DMT FDMT|Lexeo - Book Value per Share|Korro Bio, Inc. (KRRO) - Book Value per Share|Accounting Value per Share Editas Medicine, Inc. EDIT|SLN (silence-therapeutics.com) - Accounting Value of a Share|PRQR: Net Assets per Single Share|Net Assets per Share Codexis Bio|Book Value per Share SGMO (Sangamo)|Accounting Value per Share nautilus.bio (NAUT)|Book Value per Share MGX|Net Assets per Share Precision BioSciences Inc. DTIL|GBIO (Generation Bio Corp) - Book Value per Share|BOLD: Net Asset Value per Share|Net Assets per Single Share exicuretx.com|Imunon (IMNN) - Equity per Share|Book Value per Share PHIO|Accounting Value per Share Mustang Bio Corp|TransCode Therapeutics - Book Value per Share|Net Asset Value per Share BNGO (bionanogenomics.com)|Net Assets per Single Share BLUE|Net Assets per Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics - Book Value per Share|OMIC: Book Value per Share|Net Assets per Single Share Regulus Therapeutics Inc. (RGLS)|Syros Pharmaceuticals Inc. (SYRS) - Share Book Value|Book Value per Share Codex DNA (TBIO)|Equity per Share TCON|Net Assets per Single Share Unity Biotechnology UBX